Unilever beauty brand, Dermalogica, has filed suit against Target in the California Central District Court, alleging that the mass retailer sold unauthorized products on-line and in several of its California stores last fall. According to court documents, “Dermalogica goes to great lengths to control the quality of goods bearing the Dermalogica trademark,”and the beauty brand requires its authorized sellers to have “professional skin-care therapists” available for customer service. Target does not meet these requirements and was asked by Dermalogica to remove those products in 2017, which it allegedly ignored. Unilever also asserts that severly of the products sold at Target were counterfeit, expired, and/or falsely marketed.
Separately, French-owned beauty corporation, L’Oréal USA Creative LLC, owner of Skinceuticals, has filed suit against Drunk Elephant, alleging that the indie brand has infringed its patent for L-Ascorbic acid, a form of Vitamin C. The Plaintiff asks the Texas Western District court for damages, claiming that Drunk Elephant’s C-Firma Day Serum replicates the patented Skinceuticals CE Ferulic. “We believe that the scientific inventions that make our products so innovative are a strategic and competitive advantage and we are committed to protecting our valuable intellectual property,” said a spokeswoman for L’Oreal USA in a statement.